Hot Life Science Investor Mandate 3: Corporate VC Arm of Healthcare Provider Seeking Early Stage Devices, Diagnostics and Healthcare IT

21 Aug

The corporate venture capital arm of subsidiary of a US healthcare provider has closed its third fund at $225 million in 2012.The firm makes equity investments into early-stage companies of approximately $3 million to $10 million initially with additional capital reserved for follow on financings, and generally it can invest $4 million to $15 million over a life cycle. The firm seeks to invest in companies in Series A & B financing rounds, but it is open to consider companies in other stages of development. The firm is geographically agnostic, but highly prefers to invest in companies that are based in the US.

The firm is currently looking for new opportunities in the Medical Devices, Diagnostics, Healthcare IT and Healthcare Services spaces. The firm considers all classes of medical devices and focuses on companies in the clinical stage. However, the firm will also considers products that are on the market. The firm is generally opportunistic in terms of indication.

The firm primarily invests in pre-revenue private companies. The firm looks to invest in companies with a strong management team who can demonstrate relevant experience, depth and capability to build and scale the business and attract customers Ascension Ventures typically requests a Board seat or Board observation rights for each portfolio company.

If you are interested in more information about this investor and other investors tracked by LSN, please email

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

%d bloggers like this: